Features

The latest round in the title patent fight between The Broad and UC Berkelely over CRISPR/Cas9 tech goes to … Editas Medicine. The US Patent…

The two Basel-based companies Novartis and Roche invest more in research and development than all other international pharmaceutical companies, according to the 2016 EU Industrial…

Evolva, which manufactures ingredients for health, wellness and nutrition, has launched Veri-te, the brand for high-purity, sustainably produced resveratrol. The ingredient has been shown to…

The technology transfer organisation of the universities of Basel, Bern and Zurich helped more than 1,2000 new research collaborations in 2016. The funds resulting from…

‘Uberfication’ will change marketing and sales in the pharmaceutical sector, says Patrik Frei. This is already seen at healthcare companies, where digitalisation is making inroads.…

The pharmaceutical company Polyphor has received CHF 2.3 million to advance research work on a particular antibiotic. Polyphor has been very successful in developing medicines…

BaseLaunch, an accelerator initiative launched and run by the location promotion organisation BaselArea.swiss, is a new partner of the start-up accelerator Kickstart. Life sciences start-ups…

The Basel-based biopharmaceutical company Cellestia Biotech closed a CHF 8 million seed financing round. The funds will help Cellestia advance its lead cancer treatment CB-103…

US pharmaceutical company Johnson & Johnson is to acquire the biopharmaceutical company Actelion for USD 30 billion. Actelion’s research and development department will spin out…